Psychiatr. praxi. 2013;14(4):150-154

Stress and possibilities of its pharmacological modulation - do we know to measure the stress load?

Mgr.Barbora Prokopová, prof.PharmDr.Daniela Ježová, DrSc.
Laboratórium farmakologickej neuroendokrinológie, Ústav experimentálnej endokrinológie, Slovenská akadémia vied
a Katedra farmakológie a toxikológie, Farmaceutická fakulta Univerzity Komenského, Bratislava

A general treatment of stress is not possible because stress is a highly specific response to different stimuli and it is variable in each

individual. It is well known that chronic exposure to intensive stress situations may induce or speed up the development of psychiatric

disorders. Positive stress coping can reduce or prevent negative consequences, while inadequate stress coping contributes to the development

of disease states, such as affective and anxiety disorders. One of the latest concepts of stress is the allostatic theory. It defines

allostasis as a process achieving stability (homeostasis) through change. When the individual is challenged repeatedly or when the

allostatic systems remain turned on when no longer needed, it can produce a wear and tear on the body that has been termed „allostatic

load“. Allostatic load can be evaluated by an index which is calculated from several neuroendocrine, metabolic, cardiovascular and

anthropometric parameters. However, there is no unequivocal recommendation as to the nature and the number of parameters to be

considered in the allostatic load index and measurement of these parameters is often complicated under clinical conditions. Current

research provide evidence suggesting that the pharmacological treatment of the stress response, which is an unequivocal requirement

for dealing with demanding situations, is not desirable. Instead, we should focus on the prevention of its negative consequences.

Keywords: stress, stress coping, allostasis

Published: November 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Prokopová B, Ježová D. Stress and possibilities of its pharmacological modulation - do we know to measure the stress load? Psychiatr. praxi. 2013;14(4):150-154.
Download citation

References

  1. Barfield E, Moser V, Hand A, Grisel JE. ?-endorphin modulates the effect of stress on novelty-suppressed feeding. Behavioral Neuroscience. 2013 (v tlači). Go to original source...
  2. Beckie TM. A systematic review of allostatic load, health, and health disparities. Biol Res Nurs. 2012; 14: 311-346. Go to original source... Go to PubMed...
  3. Borsook D, Maleki N, Becerra L, McEwen B. Understanding Migraine through the Lens of Maladaptive Stress Responses: A Model Disease of Allostatic Load. 2012; 73: 21 9-234.
  4. Buckingham JC. Stimulation and inhibition of corticotrophin releasing factor secretion by endorphin. Neuroendocrinology. 1 986; 42: 148-152.
  5. Castro JE, Diessler S, Varea E, Márquez C, Larsen MH, Cordero MI. Personality traits in rats predict vulnerability and resilience to developing stress induced depression-like behaviors, HPA axis hyper-reactivity and brain changes in pERK1/2 activity. Psychoneuroendocrinology. 2012; 37: 120 9-1223. Go to original source... Go to PubMed...
  6. Crimminsa E, Johnstona M, Haywardb M, Seeman T. Age differences in allostatic load: an index of physiological dysregulation. Experimental Gerontology 2003; 38: 731-734. Go to original source... Go to PubMed...
  7. Danevova V, Kvetnansky R, Jezova D. Kinetics of oxytocin response to repeated restraint stress and/or chronic cold exposure. Horm Metab Res. 2013 (zaslané do tlače). Go to original source... Go to PubMed...
  8. Doenicke A, Kugler J, Penzel G, Laub M, Kalmar L, Killian I, Bezecny H. Cerebral function under etomidate, a new non-barbiturate i.v. hypnotic, Anaesthesist. 1 973; 22: 357-366.
  9. Duncko R, Novakova L, Notova P, Stepankova O, Jezova D. Behavioral and neuroendocrine changes during mental stress and repeated treatment with antidepressants in healthy men. Ann N Y Acad Sci. 2004; 1018: 524-532. Go to original source... Go to PubMed...
  10. Endler NS, Parker J. Coping Inventory for Stressful situations (CISS): Manual. Toronto, Canada: Multi-health systems. 1 990.
  11. Ficková E. Determinaty zvládania stresu: I. Teoretické prístupy. Československá psychologie. 1 993; 37: 37-46.
  12. Goldstein DS. Catecholamines and stress. Endocr. Regul. 2003; 37: 6 9-80.
  13. Grisel JE, Bartels JL, Allen SA, Turgeon VL. Influence of ? endorphin on anxious behavior in mice: interaction with EtOH. Psychopharmacology. 2008; 200: 105-115. Go to original source... Go to PubMed...
  14. Charvát J. Život, adapace a stres. Avicenum, Praha. 1 970; 13.
  15. Izáková Ľ, Ježová D. Alodsterón - Nový biologický marker alebo ďalšia možnosť v liečbe depresie? Psychiatrie. 2013; 17(1). Go to PubMed...
  16. Jezova D. Suprahypotalamové mechanizmy regulácie endokrinných funkcií. In: Všeobecná a klinická endokrinológia (A. Kreze, P. Langer, I. Klimeš, L. Stárka, J. Payer, J. Michálek, eds.) AEP, Bratislava. 2004; 127-136.
  17. Jezova D. Pohlavné rozdiely v stresovej reakcii a v účinku antidepresív. Psychiatria pre prax. 2004; 3: 126-128.
  18. Jezova D, Vigas M, Tatar P, Jurcovicova J, Palát M. Rise in plasma beta-endorphin and ACTH in response to hyperthermia in sauna. Horm Metab Res. 1 985; 17: 6 93-6 94.
  19. Jezova D, Skultetyova I, Tokarev DI, Bakos P, Vigas M. Vasopressin and oxytocin in stress. Ann N Y Acad Sci. 1 995; 771: 1 92-203.
  20. Jezova D. Jurankova E, Mosnarova A, Kriska M, Skultetyova I. Neuroendocrine response during stress with relation to gender differences. Acta Neurobiol Exp (Warsz). 1 996; 56: 77 9-785. Go to PubMed...
  21. Jezova D, Makatsori A, Duncko R, Moncek F, Jakubek M. High trait anxiety in healthy subjects is associated with low neuroendocrine activity during psychosocial stress. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 1331-1336. Go to original source... Go to PubMed...
  22. Jezova D, Vigas M, Hlavacova N, Kukumberg P. Attenuated neuroendocrine response to hypoglycemic stress in patients with panic disorder. Neuroendocrinology 2010; 92: 112-11 9. Go to original source... Go to PubMed...
  23. Jezová-Repceková D, Klimes I, Jurcovicová J, Vigas M. Effect of adrenergic receptor blockade on cortisol and GH response to insulin-induced hypoglycemia in man. Int J Clin Pharmacol Biopharm. 1 97 9; 2: 64-67.
  24. Jezová-Repceková D, Vigas M, Mikulaj L, Jurcovicová J. Plasma testosterone during bicycle ergometer exercise without and after L-dopa pretreatment. Endocrinol Exp. 1 982; 16: 3-8.
  25. Jurcovicová J, Dobrakovová M, Jezová D, Oprsalová Z, Kvetnanský R, Vigas M. Different pattern of prolactin release under various acute stress stimuli in rats. Endocrinol Exp. 1 988; 4: 235-242.
  26. Juster RP, McEwen BS, Lupien SJ. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev. 2010; 35: 2-16. Go to original source... Go to PubMed...
  27. Juster RP, Lupien S. A Sex-and Gender-Based Analysis of Allostatic Load and Physical Complaints. Gender Medicine. 2012; 9(6): 511-523. Go to original source... Go to PubMed...
  28. Karlamangla AS, Singer BH, Chodosh J, McEwen BS, Seeman TE. Urinary cortisol excretion as a predictor of incident cognitive impairment. Neurobiol Aging. 2005; 26: 80-84. Go to original source... Go to PubMed...
  29. Kubzansky LD, Kawachi I, Sparrow D. Socioeconomic status, hostility, and risk factor clustering in the Normative Aging Study: any help from the concept of allostatic load? Ann Behav Med. 1 99 9; 21: 330-338.
  30. Lundberg U. Stress hormones in health and illness: the roles of work and tender Psychoneuroendocrinology. 2005; 30: 1017-1021. Go to original source... Go to PubMed...
  31. McEwen BS. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci. 1 998; 840: 33-44.
  32. McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med. 1 993; 153: 20 93-2101.
  33. McEwen BS. Stress and hippocampal plasticity. Annu. Rev. Neurosci. 1 99 9; 22: 105-122. Go to PubMed...
  34. McEwen BS. Early life influences on life-long patterns of behavior and health. Ment. Retard. Dev. Disabil. Res. Rev. 2003; 9: 14 9-154. Go to original source... Go to PubMed...
  35. Neumann ID, Landgraf R. Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci. 2012; 35: 64 9-65 9. Go to original source... Go to PubMed...
  36. Ondrejcakova M, Bakos J, Garafova A, Kovacs L, Kvetnansky R, Jezova D. Neuroendocrine and cardiovascular parameters during simulation of stress-induced rise in circulating oxytocin in the rat. Stress. 2010; 13: 314-322. Go to original source... Go to PubMed...
  37. Repceková D, Mikulaj L. Plasma testosterone of rats subjected to immobilization stress and/or HCG administration. Horm Res. 1 977; 8: 51-57.
  38. Rubin RT, Poland RE, Tower BB. Prolactin-related testosterone secretion in normal adult men. J Clin Endocrinol Metab. 1 976; 42: 112-116.
  39. Seeman TE, Singer BH, Rowe JW, Horwitz RI, McEwen BS. Price of adaptation-allostatic load and its health consequences. MacArthur studies of successful aging. Arch Intern Med. 1 997; 157: 225 9-2268. Go to original source...
  40. Seeman TE, Singer BH, Ryff CD, Dienberg Love G, Levy-Storms L. Social relationships, gender, and allostatic load across two age cohorts. Psychosom Med. 2002; 64(3): 3 95-406. Go to original source... Go to PubMed...
  41. Selye H. A syndrome produced by diverse noxious agents. Nature. 1 936; 32: 138.
  42. Seplaki CL, Goldman N, Weinstein M, Lin YH. How are biomarkers related to physical and mental well-being? J Gerontol A Biol Sci Med Sci. 2004; 5 9(3): 201-217. Go to original source... Go to PubMed...
  43. Seplaki CL, Goldman N, Glei D, Weinstein M. A comparative analysis of measurement approaches for physiological dysregulation in an older population. Exp Gerontol. 2005; 40(5): 438-44 9. Go to original source... Go to PubMed...
  44. Seplaki CL, Goldman N, Weinstein M, Lin YH. Measurement of cumulative physiological dysregulation in an older population. Demography. 2006; 43(1): 165-183. Go to original source... Go to PubMed...
  45. Schmidt DR, Dantas RA, Marziale MH. Anxiety and depression among nursing professionals who work in surgical units. Rev Esc Enferm USP. 2011; 45: 487-4 93. Go to original source... Go to PubMed...
  46. Schnorpfeil P, Noll A, Schulze R, Ehlert U, Frey K, Fischer JE. Allostatic load and work conditions. Soc Sci Med. 2003; 57: 647-656. Go to original source... Go to PubMed...
  47. Singer B, Ryff CD, Seeman T. Operationalizing allostatic load. In: Allostasis, Homeostasis and the cost of physiological adaption. (Schulkin J, eds) Press syndicate of the university of Cambridge, UK. 2004; 113-14 9. Go to original source...
  48. Sterling P, Eyer J. Allostasis: A New Paradigm to Explain Arousal Pathology. In: Handbook of life stress, cognition, and health. 1 988; ISBN 0471 9126 97.
  49. Tatár P, Kvetňanský R, Štrec V, Vigaš J, Jurčovičová J, Ježová D. Plasma catecholamines and adenopituitary hormones during hyperthermia in sauna in man. In: Stress: The Role of Catecholamines and other neurotransmitters. (Usdin E, Kvetňanský R, Axelrod J, eds) Gordon and Breach Science Publishers. 1 984; 2: 91 9-928.
  50. Vermetten E, Bremner JD. Circuits and systems in stress. I. Preclinical studies. Depress Anxiety. 2002; 15: 126-147. Go to original source... Go to PubMed...
  51. Vigaš M. Neuroendokrinné mechanizmy stresovej odpovede In: Praktická endokrinológia, (Kreze A, Langer P, Klimeš I, Lichardus B, eds) Slovak academic Press, Bratislava. 1 993: 60-65.
  52. Vigaš M, Koška J. Patofyziológia hypotalamo-hypofýzového systému. In: Všeobecná a klinická endokrinológia (Kreze A, Langer P, Klimeš I, Stárka L, Payer J, Michálek J, eds) AEP, Bratislava. 2004; 137-151.
  53. Yang Y, Kozloski M. Sex Differences in Age Trajectories of Physiological Dysregulation: Inflammation, Metabolic Syndrome, and Allostatic Load. J Gerontol A Biol Sci Med Sci. 2011; 66A(5): 4 93-500. Go to original source... Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.